Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 31;14(7):e078370.
doi: 10.1136/bmjopen-2023-078370.

Loss to follow-up and its predictors among children living with HIV on antiretroviral therapy, southern Oromia, Ethiopia: a 5-year retrospective cohort study

Affiliations

Loss to follow-up and its predictors among children living with HIV on antiretroviral therapy, southern Oromia, Ethiopia: a 5-year retrospective cohort study

Assefa Washo Bankere et al. BMJ Open. .

Abstract

Background: Loss to follow-up (LTFU) among paediatric patients living with HIV presents a significant challenge to the global scale-up of life-saving antiretroviral therapy (ART).

Objectives: This study aims to estimate LTFU incidence and its determinants among children with HIV on ART in Shashemene town public health institutions, Oromia, Ethiopia.

Design: A retrospective cohort study from 1 January 2015 to 30 December 2020.

Setting: This study was conducted in Shashemene town, Oromia, Ethiopia.

Participants: Medical records of 269 children receiving ART at health facilities in Shashemene town were included.

Methods: Data from patients' medical records were collected using a standardised checklist. EpiData V.3.1 was employed for data entry, while Statistical Package for the Social Sciences (SPSS) V.25 facilitated analysis. The Kaplan-Meier survival curve was used for estimation of survival time. To measure association, adjusted HRs (AHRs) with 95% CIs were calculated. Both bivariable and multivariable Cox proportional hazards regression models were employed to identify predictors of LTFU.

Results: Of the 269 children living with HIV included in the final analysis, 43 (16%) were lost to follow-up. The overall incidence rate of LTFU was 3.3 (95% CI 2.4 to 4.4) per 100 child-years of observation. Age less than 5 years (AHR 0.03, 95% CI 0.00 to 0.36), non-orphan status of the child (AHR 0.13, 95% CI 0.05 to 0.34), < 30 min distance to health facility (AHR 0.24, 95% CI 0.08 to 0.73), disclosed HIV status (AHR 0. 32, 95% CI 0.13 to 0.80), history of opportunistic infection (AHR 3.54, 95% CI 1.15 to 10.87) and low CD4 count (AHR 5.17, 95% CI 2.08 to 12.85) were significant predictors of LTFU.

Conclusion: The incidence rate of LTFU was lower compared with other studies in Ethiopia. This result indicated that age less than 5 years, non-orphans, low CD4, disclosed HIV status and distance from health facility were predictors of LTFU.

Keywords: Epidemiology; HIV & AIDS; PUBLIC HEALTH.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1. The cumulative probability of loss to follow-up (LTFU) among children on ART in health facilities, Shashemene town. As the children receive ART for a longer period of time the probability of LTFU increases. ART, antiretroviral therapy.

Similar articles

Cited by

References

    1. UNAIDS . AIDS info website; 2019. [-Jul-2020]. UNAIDS. 2020 HIV and AIDS estimates ethiopia, UNAIDS country factsheets – 2020 fact sheet.http://aidsinfo.unaids.org/ Available. Accessed.
    1. UNAIDS Global AIDS update 2019. 2019
    1. WHO . Switzerland: Glion; 2015. WHO working group on HIV incidence assays: estimating HIV incidence using HIV case surveillance: meeting report; pp. 10–1.
    1. FMOH E. National Consolidated Guidelines for Comprehensive HIV Prevention, Care and Treatment. 2018.
    1. Moreira-Silva SF, Zandonade E, Miranda AE. Mortality in children and adolescents vertically infected by HIV receiving care at a referral hospital in Vitoria, Brazil. BMC Infect Dis. 2015;15:155. doi: 10.1186/s12879-015-0893-0. - DOI - PMC - PubMed